Free Trial

River Global Investors LLP Cuts Stock Position in McKesson Co. (NYSE:MCK)

River Global Investors LLP lowered its holdings in shares of McKesson Co. (NYSE:MCK - Free Report) by 26.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,883 shares of the company's stock after selling 6,055 shares during the quarter. McKesson makes up approximately 1.5% of River Global Investors LLP's holdings, making the stock its 13th biggest position. River Global Investors LLP's holdings in McKesson were worth $7,816,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in MCK. OFI Invest Asset Management purchased a new stake in McKesson in the third quarter worth about $26,000. Legacy Financial Group LLC purchased a new position in McKesson during the third quarter valued at approximately $27,000. BKM Wealth Management LLC bought a new position in shares of McKesson in the fourth quarter worth approximately $31,000. WASHINGTON TRUST Co increased its stake in shares of McKesson by 42.5% in the fourth quarter. WASHINGTON TRUST Co now owns 114 shares of the company's stock worth $53,000 after purchasing an additional 34 shares in the last quarter. Finally, Milestone Investment Advisors LLC bought a new stake in shares of McKesson during the 3rd quarter valued at $61,000. Hedge funds and other institutional investors own 85.07% of the company's stock.

Insider Buying and Selling

In other McKesson news, EVP Leann B. Smith sold 186 shares of the business's stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total value of $92,256.00. Following the completion of the transaction, the executive vice president now directly owns 1,511 shares in the company, valued at $749,456. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Brian S. Tyler sold 3,473 shares of the company's stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the transaction, the chief executive officer now directly owns 43,445 shares of the company's stock, valued at approximately $22,789,074.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Leann B. Smith sold 186 shares of the stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total transaction of $92,256.00. Following the completion of the transaction, the executive vice president now directly owns 1,511 shares of the company's stock, valued at $749,456. The disclosure for this sale can be found here. 0.21% of the stock is currently owned by company insiders.


McKesson Stock Performance

MCK stock traded down $1.41 during midday trading on Friday, reaching $528.86. 866,981 shares of the company traded hands, compared to its average volume of 626,262. The firm has a market capitalization of $69.50 billion, a price-to-earnings ratio of 23.96, a P/E/G ratio of 1.41 and a beta of 0.45. McKesson Co. has a 52-week low of $352.34 and a 52-week high of $544.81. The business has a 50 day moving average of $530.38 and a 200-day moving average of $492.08.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings data on Wednesday, February 7th. The company reported $7.74 EPS for the quarter, topping the consensus estimate of $7.05 by $0.69. McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. The company had revenue of $80.90 billion for the quarter, compared to the consensus estimate of $77.93 billion. During the same period last year, the business posted $6.90 EPS. McKesson's quarterly revenue was up 14.8% on a year-over-year basis. Research analysts anticipate that McKesson Co. will post 27.59 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Monday, June 3rd will be given a $0.62 dividend. This represents a $2.48 annualized dividend and a dividend yield of 0.47%. The ex-dividend date is Friday, May 31st. McKesson's payout ratio is 11.24%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on MCK. Mizuho increased their price target on McKesson from $450.00 to $505.00 and gave the stock a "neutral" rating in a research note on Friday, February 9th. Citigroup lifted their target price on McKesson from $575.00 to $620.00 and gave the company a "buy" rating in a research note on Tuesday. Leerink Partnrs restated an "outperform" rating on shares of McKesson in a research note on Monday, February 26th. Argus lifted their price objective on shares of McKesson from $510.00 to $570.00 and gave the company a "buy" rating in a research report on Wednesday, April 10th. Finally, Morgan Stanley upped their target price on shares of McKesson from $522.00 to $548.00 and gave the stock an "overweight" rating in a research report on Monday, April 15th. Two equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, McKesson has an average rating of "Moderate Buy" and an average price target of $536.71.

View Our Latest Research Report on McKesson

McKesson Company Profile

(Free Report)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Featured Stories

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

→ $1,500 to $9,400 in one month? (A.I. Trade List) (From Prosper Trading Academy) (Ad)

Should you invest $1,000 in McKesson right now?

Before you consider McKesson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.

While McKesson currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Featured Articles and Offers

Search Headlines: